Hydroxyurée, 98%, poudre

Code: h8627-10g D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Hydroxyurea has been used:for cell cycle synchronization in MCF-7 human breast carcinoma cells, Schizosaccharomyces pombe, primary root of seedlingas a d...


en savoir plus

Votre prix
£217.00 10G

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Hydroxyurea has been used:for cell cycle synchronization in MCF-7 human breast carcinoma cells, Schizosaccharomyces pombe, primary root of seedlingas a drug for treating the parasite Leishmania mexicana in cell viability and cell cycle assay as an inhibitor in the cell adhesion and motility assay in Caki control and CD9 knockdown cells

Biochem/physiol Actions

Anti-neoplastic. Inactivates ribonucleoside reductase by forming a free radical nitroxide that binds a tyrosyl free radical in the active site of the enzyme. This blocks the synthesis of deoxynucleotides, which inhibits DNA synthesis and induces synchronization or cell death in S-phase.

Features and Benefits

This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

1, 5, 10, 25, 100 g in poly bottle

assay98%
colorwhite
formpowder
Gene Informationhuman ... CA1(759), CA2(760), CYP1A2(1544), RRM1(6240), RRM2(6241), RRM2B(50484)
InChI keyVSNHCAURESNICA-UHFFFAOYSA-N
InChI1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)
Quality Level200
SMILES stringNC(=O)NO
solubilityH2O: 50 mg/mL
storage temp.2-8°C
Code
Description
Unité de vente
Prix annoncé
Qté
H8627-5G
Unité:5G
Prix annoncé: £101.00
Source:Prix annoncé
H8627-100G
Unité:100G
Prix annoncé: £1,110.00
Source:Prix annoncé
H8627-1G
Unité:1G
Prix annoncé: £28.00
Source:Prix annoncé
H8627-25G
Unité:25G
Prix annoncé: £356.00
Source:Prix annoncé
Cas Number127-07-1
Ce produit répond aux critères suivants: